Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To assess the safety and tolerability (including an assessment of motor symptoms using the UPDRS) of open label 5-10 mg/day Aricept® in Parkinson's disease patients with dementia, who have completed the week 24 visit in the double-blind Aricept study E2020-E044-316.
Critère d'inclusion
- Dementia associated with Parkinson's disease